Skip to main content

Table 1 Patient characteristics

From: Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival

Variable Lung cancer patients
Total sample size, N 38
Gender, N (males/female) 14/24
Age, mean ± SD (min, max) 70 ± 9 (56, 91)
Packs per year, mean ± SD (min, max) 33 ± 25 (0, 100)
Current smoker, N (%) 6 (15.79%)
Stage  
 Stage IA, N (%) 21 (55.3%)
 Stage IB, N (%) 17 (44.7%)
Developed lymphovascular invasion, N (%) 6 (15.8%)
Developed pleural invasion, N (%) 13 (34.2%)
Progressed, N (%) 14 (36.84%)
 Local–regional, N 4
 Second primary, N 3
 Distal, N 7